NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Mirae Asset Capital Life Science

Mirae Asset Capital Life Science

Boston, Massachusettsmiraeasset.com

Overview

Mirae Asset Capital Life Science is a venture capital firm that invests in private biotechnology companies from seed to series C with a primary focus on therapeutics, diagnostics, and AI/ML tools for drug discovery.

Year Founded

2023

Portfolio Companies

3

Investments

Mirae Asset Capital Life Science investments
CompanyDateStageLead
Precede BiosciencesJan 2026Series BCo-investor
Attovia TherapeuticsApr 2025Series CCo-investor
Accent TherapeuticsJan 2024Series CLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.